Code blue: Acinetobacter baumannii, a nosocomial pathogen with a role in the oral cavity
- PMID: 25052812
- PMCID: PMC4617346
- DOI: 10.1111/omi.12072
Code blue: Acinetobacter baumannii, a nosocomial pathogen with a role in the oral cavity
Abstract
Actinetobacter baumannii is an important nosocomial pathogen that can cause a wide range of serious conditions including pneumonia, meningitis, necrotizing fasciitis and sepsis. It is also a major cause of wound infections in military personnel injured during the conflicts in Afghanistan and Iraq, leading to its popular nickname of 'Iraqibacter'. Contributing to its success in clinical settings is resistance to environmental stresses such as desiccation and disinfectants. Moreover, in recent years there has been a dramatic increase in the number of A. baumannii strains with resistance to multiple antibiotic classes. Acinetobacter baumannii is an inhabitant of oral biofilms, which can act as a reservoir for pneumonia and chronic obstructive pulmonary disease. Subgingival colonization by A. baumannii increases the risk of refractory periodontitis. Pathogenesis of the organism involves adherence, biofilm formation and iron acquisition. In addition, A. baumannii can induce apoptotic cell death in epithelial cells and kill hyphal forms of Candida albicans. Virulence factors that have been identified include pili, the outer membrane protein OmpA, phospholipases and extracellular polysaccharide. Acinetobacter baumannii can sense blue light through a blue-light sensing using flavin (BLUF) domain protein, BlsA. The resulting conformational change in BlsA leads to changes in gene expression, including virulence genes.
Keywords: Acinetobacter; infection models; oral microbiology; periodontal disease; respiratory tract microbiology.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Figures
Similar articles
-
[Current approaches to explain the virulence of Acinetobacter baumannii].Mikrobiyol Bul. 2011 Apr;45(2):371-80. Mikrobiyol Bul. 2011. PMID: 21644082 Review. Turkish.
-
[Investigation of the virulence factors of multidrug-resistant Acinetobacter baumannii isolates].Mikrobiyol Bul. 2014 Jan;48(1):70-81. Mikrobiyol Bul. 2014. PMID: 24506717 Turkish.
-
Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models.FEMS Microbiol Rev. 2013 Mar;37(2):130-55. doi: 10.1111/j.1574-6976.2012.00344.x. Epub 2012 Jun 18. FEMS Microbiol Rev. 2013. PMID: 22568581 Review.
-
Association of biofilm production with colonization among clinical isolates of Acinetobacter baumannii.Korean J Intern Med. 2017 Mar;32(2):345-351. doi: 10.3904/kjim.2015.287. Epub 2016 Sep 22. Korean J Intern Med. 2017. PMID: 27653617 Free PMC article.
-
An overview of Acinetobacter baumannii pathogenesis: Motility, adherence and biofilm formation.Microbiol Res. 2021 Jun;247:126722. doi: 10.1016/j.micres.2021.126722. Epub 2021 Feb 4. Microbiol Res. 2021. PMID: 33618061 Review.
Cited by
-
Multidrug-resistant Acinetobacter spp. from hospital intensive care units in Brazilian Amazon.Braz J Infect Dis. 2023 Nov-Dec;27(6):103687. doi: 10.1016/j.bjid.2023.103687. Epub 2023 Nov 14. Braz J Infect Dis. 2023. PMID: 37977198 Free PMC article.
-
Upper respiratory tract microbiome profiles in SARS-CoV-2 Delta and Omicron infected patients exhibit variant specific patterns and robust prediction of disease groups.Microbiol Spectr. 2023 Dec 12;11(6):e0236823. doi: 10.1128/spectrum.02368-23. Epub 2023 Oct 31. Microbiol Spectr. 2023. PMID: 37905804 Free PMC article.
-
The interactions of Candida albicans with gut bacteria: a new strategy to prevent and treat invasive intestinal candidiasis.Gut Pathog. 2023 Jun 27;15(1):30. doi: 10.1186/s13099-023-00559-8. Gut Pathog. 2023. PMID: 37370138 Free PMC article. Review.
-
Prediction of Putative Epitope Peptides against BaeR Associated with TCS Adaptation in Acinetobacter baumannii Using an In Silico Approach.Medicina (Kaunas). 2023 Feb 11;59(2):343. doi: 10.3390/medicina59020343. Medicina (Kaunas). 2023. PMID: 36837545 Free PMC article.
-
Beta-Lactam Antibiotic Resistance Genes in the Microbiome of the Public Transport System of Quito, Ecuador.Int J Environ Res Public Health. 2023 Jan 20;20(3):1900. doi: 10.3390/ijerph20031900. Int J Environ Res Public Health. 2023. PMID: 36767267 Free PMC article.
References
-
- Ali RW, Velcescu C, Jivanescu MC, Lofthus B, Skaug N. Prevalence of 6 putative periodontal pathogens in subgingival plaque samples from Romanian adult periodontitis patients. J Clin Periodontol. 1996;23:133–139. - PubMed
-
- Averhoff B, Friedrich A. Type IV pili-related natural transformation systems: DNA transport in mesophilic and thermophilic bacteria. Arch Microbiol. 2003;180:385–393. - PubMed
-
- Ayraud-Thevenot S, Huart C, Mimoz O, et al. Control of multi-drug-resistant Acinetobacter baumannii outbreaks in an intensive care unit: feasibility and economic impact of rapid unit closure. J Hosp Infect. 2012;82:290–292. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- AI107978/AI/NIAID NIH HHS/United States
- R01 DE023193/DE/NIDCR NIH HHS/United States
- DE011111/DE/NIDCR NIH HHS/United States
- R21 AI107978/AI/NIAID NIH HHS/United States
- DE017921/DE/NIDCR NIH HHS/United States
- R01 DE016690/DE/NIDCR NIH HHS/United States
- R37 DE011111/DE/NIDCR NIH HHS/United States
- DE016690/DE/NIDCR NIH HHS/United States
- DE022867/DE/NIDCR NIH HHS/United States
- R01 DE012505/DE/NIDCR NIH HHS/United States
- AI069321/AI/NIAID NIH HHS/United States
- DE012505/DE/NIDCR NIH HHS/United States
- R01 AI069321/AI/NIAID NIH HHS/United States
- R21 DE022867/DE/NIDCR NIH HHS/United States
- R01 DE017921/DE/NIDCR NIH HHS/United States
- R01 DE011111/DE/NIDCR NIH HHS/United States
- DE023193/DE/NIDCR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
